Advanced search
Publication Cover
Expert Opinion on Drug Discovery Volume 11, 2016 - Issue 7
Submit an article Journal homepage
1,053
Views
45
CrossRef citations to date
0
Altmetric
Review

Targeting the dopamine D3 receptor: an overview of drug design strategies

Antoni CortésCentro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Spain;Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, Institute of Biomedicine of the University of Barcelona (IBUB), University of Barcelona, Barcelona, Spain
,
Estefanía MorenoCentro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Spain;Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, Institute of Biomedicine of the University of Barcelona (IBUB), University of Barcelona, Barcelona, Spain
,
Mar Rodríguez-RuizCentro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Spain;Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, Institute of Biomedicine of the University of Barcelona (IBUB), University of Barcelona, Barcelona, Spain
,
Enric I. CanelaCentro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Spain;Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, Institute of Biomedicine of the University of Barcelona (IBUB), University of Barcelona, Barcelona, Spain
&
Vicent CasadóCentro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Spain;Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, Institute of Biomedicine of the University of Barcelona (IBUB), University of Barcelona, Barcelona, SpainCorrespondence[email protected]
Pages 641-664 | Received 12 Feb 2016, Accepted 29 Apr 2016, Published online: 30 May 2016

Citations (45)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Verònica Casadó-Anguera & Vicent Casadó. (2022) Unmasking allosteric-binding sites: novel targets for GPCR drug discovery. Expert Opinion on Drug Discovery 17:8, pages 897-923.
Read now
Verònica Casadó-Anguera, Antoni Cortés, Vicent Casadó & Estefanía Moreno. (2019) Targeting the receptor-based interactome of the dopamine D1 receptor: looking for heteromer-selective drugs. Expert Opinion on Drug Discovery 14:12, pages 1297-1312.
Read now
Harini Sarva & Claire Henchcliffe. (2018) Valbenazine as the first and only approved treatment for adults with tardive dyskinesia. Expert Review of Clinical Pharmacology 11:3, pages 209-217.
Read now

Articles from other publishers (42)

Mengyuan Jiang, Shan Li, Hui Gao, Wenjing Peng, Xiaoqing Cao, Cailing Zhu, Mengjie Su, Zengqiang Wu & Chunmei Yu. (2023) Stretchable sensor based on NiO-Ni(OH)2 and single-walled carbon nanotubes for in situ and real-time monitoring of dopamine release from cells. Microchemical Journal 195, pages 109488.
Crossref
Ava Bachari, Nazim Nassar, Ellen Schanknecht, Srinivasareddy Telukutla, Terrence Jerald Piva & Nitin Mantri. (2023) Rationalizing a prospective coupling effect of cannabinoids with the current pharmacotherapy for melanoma treatment. WIREs Mechanisms of Disease.
Crossref
Radomir Juza, Kamil Musilek, Eva Mezeiova, Ondrej Soukup & Jan Korabecny. (2022) Recent advances in dopamine D 2 receptor ligands in the treatment of neuropsychiatric disorders . Medicinal Research Reviews 43:1, pages 55-211.
Crossref
Petr Morozov, Roman Bekker & Youri Bykov. (2022) Cariprazine's Potential in Improving Social Dysfunction in Patients With Schizophrenia: A Perspective. Frontiers in Psychiatry 13.
Crossref
Jin Cai, Yuhong Wang, Xixi Chen & Min Ji. (2022) New class of benzothiophene morpholine analogues with high selectivity and affinity were designed and evaluated for anti‐drug addiction. Chemical Biology & Drug Design 99:4, pages 634-649.
Crossref
Daniel Pulido, Verònica Casadó-Anguera, Marc Gómez-Autet, Natàlia Llopart, Estefanía Moreno, Nil Casajuana-Martin, Sergi Ferré, Leonardo Pardo, Vicent Casadó & Miriam Royo. (2022) Heterobivalent Ligand for the Adenosine A 2A –Dopamine D 2 Receptor Heteromer . Journal of Medicinal Chemistry 65:1, pages 616-632.
Crossref
Hayrettin Ozan Gulcan. (2022) Selected Natural and Synthetic Agents Effective against Parkinson’s Disease with Diverse Mechanisms. Current Topics in Medicinal Chemistry 22:3, pages 199-208.
Crossref
Jinbin Xu. 2023. Therapeutic Applications of Dopamine D3 Receptor Function. Therapeutic Applications of Dopamine D3 Receptor Function 89 107 .
L. X. Vásquez-Bochm, Isabel Velázquez-López, Rachel Mata, Alejandro Sosa-Peinado, Patricia Cano-Sánchez & Martin González-Andrade. (2021) Application of a Fluorescent Biosensor in Determining the Binding of 5-HT to Calmodulin. Chemosensors 9:9, pages 250.
Crossref
Jin Cai, Mingqi Huang, Yuhong Wang, Xixi Chen & Min Ji. (2021) Design, synthesis and preliminary bioactivity evaluation of bitopic benzopyranomorpholine analogues as selective dopamine D3 receptor ligands as anti-drug addiction therapeutic agents. Bioorganic & Medicinal Chemistry Letters 48, pages 128269.
Crossref
Kanika Singh, Nazim Nassar, Ava Bachari, Ellen Schanknecht, Srinivasareddy Telukutla, Roby Zomer, Terrence J. Piva & Nitin Mantri. (2021) The Pathophysiology and the Therapeutic Potential of Cannabinoids in Prostate Cancer. Cancers 13:16, pages 4107.
Crossref
Kathryn Lanza & Christopher Bishop. (2021) Dopamine D3 Receptor Plasticity in Parkinson’s Disease and L-DOPA-Induced Dyskinesia. Biomedicines 9:3, pages 314.
Crossref
Anni Allikalt, Tõnis Laasfeld, Mihkel Ilisson, Sergei Kopanchuk & Ago Rinken. (2020) Quantitative analysis of fluorescent ligand binding to dopamine D 3 receptors using live‐cell microscopy . The FEBS Journal 288:5, pages 1514-1532.
Crossref
Béla Kiss, István Laszlovszky, Balázs Krámos, András Visegrády, Amrita Bobok, György Lévay, Balázs Lendvai & Viktor Román. (2021) Neuronal Dopamine D3 Receptors: Translational Implications for Preclinical Research and CNS Disorders. Biomolecules 11:1, pages 104.
Crossref
Matthew Bucklin. (2021) A 5-Factor Framework for Assessing Tobacco Use Disorder. Tobacco Use Insights 14, pages 1179173X2199835.
Crossref
Pengfei Yang, William C. Knight, Huifangjie Li, Yingqiu Guo, Joel S. Perlmutter, Tammie L.S. Benzinger, John C. Morris & Jinbin Xu. (2020) Dopamine D1 + D3 receptor density may correlate with parkinson disease clinical features. Annals of Clinical and Translational Neurology 8:1, pages 224-237.
Crossref
Mei-Xue Dong, Guang-Hui Chen & Ling Hu. (2020) Dopaminergic System Alteration in Anxiety and Compulsive Disorders: A Systematic Review of Neuroimaging Studies. Frontiers in Neuroscience 14.
Crossref
Mark J. Millan, Anne Dekeyne, Alain Gobert, Mauricette Brocco, Clotilde Mannoury la Cour, Jean-Claude Ortuno, David Watson & Kevin C.F. Fone. (2020) Dual-acting agents for improving cognition and real-world function in Alzheimer’s disease: Focus on 5-HT6 and D3 receptors as hubs. Neuropharmacology 177, pages 108099.
Crossref
Baruc Campos Campos, Arturo Ávalos‐Fuentes, Celia Piña Leyva, Rodolfo Sánchez‐Zavaleta, Santiago Loya‐López, Claudia Rangel‐Barajas, Gerardo Leyva‐Gómez, Hernán Cortés, David Erlij & Benjamín Florán. (2020) Coexistence of D 3 R typical and atypical signaling in striatonigral neurons during dopaminergic denervation. Correlation with D 3 nf expression changes . Synapse 74:8.
Crossref
Jean Claude Martel & Silvia Gatti McArthur. (2020) Dopamine Receptor Subtypes, Physiology and Pharmacology: New Ligands and Concepts in Schizophrenia. Frontiers in Pharmacology 11.
Crossref
Magdalena Pisula, Ewelina Dróżdż & Elżbieta Chełmecka. (2020) Molecular modeling as a stage of searching for new substances with potential therapeutic significance. Annales Academiae Medicae Silesiensis 74, pages 91-98.
Crossref
Pengfei Yang, Joel S. Perlmutter, Tammie L.S. Benzinger, John C. Morris & Jinbin Xu. (2020) Dopamine D3 receptor: A neglected participant in Parkinson Disease pathogenesis and treatment?. Ageing Research Reviews 57, pages 100994.
Crossref
Kathryn Lanza, Katherine Chemakin, Sarah Lefkowitz, Carolyn Saito, Nicole Chambers & Christopher Bishop. (2019) Reciprocal cross-sensitization of D1 and D3 receptors following pharmacological stimulation in the hemiparkinsonian rat. Psychopharmacology 237:1, pages 155-165.
Crossref
Edythe D. London. 2020. Recent Advances in Research on Impulsivity and Impulsive Behaviors. Recent Advances in Research on Impulsivity and Impulsive Behaviors 53 71 .
Anver Basha Shaik, Vivek Kumar, Alessandro Bonifazi, Adrian M. Guerrero, Sophie L. Cemaj, Alexandra Gadiano, Jenny Lam, Zheng-Xiong Xi, Rana Rais, Barbara S. Slusher & Amy Hauck Newman. (2019) Investigation of Novel Primary and Secondary Pharmacophores and 3-Substitution in the Linking Chain of a Series of Highly Selective and Bitopic Dopamine D 3 Receptor Antagonists and Partial Agonists . Journal of Medicinal Chemistry 62:20, pages 9061-9077.
Crossref
Xiongfeng Pan, Atipatsa C. Kaminga, Shi Wu Wen, Xinyin Wu, Kwabena Acheampong & Aizhong Liu. (2019) Dopamine and Dopamine Receptors in Alzheimer's Disease: A Systematic Review and Network Meta-Analysis. Frontiers in Aging Neuroscience 11.
Crossref
Francisco O. Battiti, Sophie L. Cemaj, Adrian M. Guerrero, Anver Basha Shaik, Jenny Lam, Rana Rais, Barbara S. Slusher, Jeffery R. Deschamps, Greg H. Imler, Amy Hauck Newman & Alessandro Bonifazi. (2019) The Significance of Chirality in Drug Design and Synthesis of Bitopic Ligands as D 3 Receptor (D 3 R) Selective Agonists . Journal of Medicinal Chemistry 62:13, pages 6287-6314.
Crossref
Estefanía Moreno, Milena Cavic, Ana Krivokuca, Vicent Casadó & Enric Canela. (2019) The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?. Frontiers in Pharmacology 10.
Crossref
Francesca Casoni, Andrea Galbiati & Luigi Ferini-Strambi. 2019. Pharmacology of Restless Legs Syndrome (RLS). Pharmacology of Restless Legs Syndrome (RLS) 21 35 .
Antoni Cortés, Verònica Casadó-Anguera, Estefanía Moreno & Vicent Casadó. 2019. Pharmacology of Restless Legs Syndrome (RLS). Pharmacology of Restless Legs Syndrome (RLS) 37 78 .
Xudong Cao, Yifang Zhang, Yin Chen, Yinli Qiu, Minquan Yu, Xiangqing Xu, Xin Liu, Bi-Feng Liu, Liangren Zhang & Guisen Zhang. (2018) Synthesis and Biological Evaluation of Fused Tricyclic Heterocycle Piperazine (Piperidine) Derivatives As Potential Multireceptor Atypical Antipsychotics. Journal of Medicinal Chemistry 61:22, pages 10017-10039.
Crossref
Benhua Zhou, Kwon Ho Hong, Min Ji & Jin Cai. (2018) Design, synthesis, and biological evaluation of structurally constrained hybrid analogues containing ropinirole moiety as a novel class of potent and selective dopamine D3 receptor ligands. Chemical Biology & Drug Design 92:3, pages 1597-1609.
Crossref
Kathryn Lanza, Samantha M. Meadows, Nicole E. Chambers, Emily Nuss, Molly M. Deak, Sergi Ferré & Christopher Bishop. (2018) Behavioral and cellular dopamine D1 and D3 receptor-mediated synergy: Implications for L-DOPA-induced dyskinesia. Neuropharmacology 138, pages 304-314.
Crossref
Oscar Solís & Rosario Moratalla. (2018) Dopamine receptors: homomeric and heteromeric complexes in l-DOPA-induced dyskinesia. Journal of Neural Transmission 125:8, pages 1187-1194.
Crossref
Benhua Zhou, Min Ji & Jin Cai. (2018) Design, synthesis and biological evaluation of bitopic arylpiperazine-hexahydro-pyrazinoquinolines as preferential dopamine D3 receptor ligands. Bioorganic Chemistry 77, pages 125-135.
Crossref
Yongkai Cao, Ningning Sun, Jiumei Zhang, Zhiguo Liu, Yi-zhe Tang, Zhengzhi Wu, Kyeong-Man Kim & Seung Hoon Cheon. (2018) Design, synthesis, and evaluation of bitopic arylpiperazine-phthalimides as selective dopamine D 3 receptor agonists . MedChemComm 9:9, pages 1457-1465.
Crossref
Sean W. Reilly, Suzy Griffin, Michelle Taylor, Kristoffer Sahlholm, Chi-Chang Weng, Kuiying Xu, Daniel A. Jacome, Robert R. Luedtke & Robert H. Mach. (2017) Highly Selective Dopamine D 3 Receptor Antagonists with Arylated Diazaspiro Alkane Cores . Journal of Medicinal Chemistry 60:23, pages 9905-9910.
Crossref
ChengPeng Yu, XiaoYan Zhou, Qiang Fu, QingHua Peng, Ki-Wan Oh & ZhenZhen Hu. (2017) A New Insight into the Role of CART in Cocaine Reward: Involvement of CaMKII and Inhibitory G-Protein Coupled Receptor Signaling. Frontiers in Cellular Neuroscience 11.
Crossref
Noor Hussein, Haneen Amawi, Chandrabose Karthikeyan, F. Scott Hall, Roopali Mittal, Piyush Trivedi, Charles R. AshbyJr.Jr. & Amit K. Tiwari. (2017) The dopamine D 3 receptor antagonists PG01037, NGB2904, SB277011A, and U99194 reverse ABCG2 transporter-mediated drug resistance in cancer cell lines. Cancer Letters 396, pages 167-180.
Crossref
Alessio De Simone, Debora Russo, Gian Filippo Ruda, Alessandra Micoli, Mariarosaria Ferraro, Rita Maria Concetta Di Martino, Giuliana Ottonello, Maria Summa, Andrea Armirotti, Tiziano Bandiera, Andrea Cavalli & Giovanni Bottegoni. (2017) Design, Synthesis, Structure–Activity Relationship Studies, and Three-Dimensional Quantitative Structure–Activity Relationship (3D-QSAR) Modeling of a Series of O -Biphenyl Carbamates as Dual Modulators of Dopamine D3 Receptor and Fatty Acid Amide Hydrolase . Journal of Medicinal Chemistry 60:6, pages 2287-2304.
Crossref
Ramona Schrage & Evi Kostenis. (2017) Functional selectivity and dualsteric/bitopic GPCR targeting. Current Opinion in Pharmacology 32, pages 85-90.
Crossref
MahdiEskandarian Boroujeni & Mossa Gardaneh. (2017) Umbilical cord: an unlimited source of cells differentiable towards dopaminergic neurons. Neural Regeneration Research 12:7, pages 1186.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.